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1 Introduction
Adoption of cancer screening by at risk populations aﬀects cancer incidence and mortality and the
demand for health services including screening and diagnostic tests as well as treatment for detected
disease. Understanding trends in screening use can inform our interpretation of observed changes in
cancer incidence and mortality rates and may aid in the projection of future health care utilization
needs. Longitudinal estimates of the proportion of people who have been screened for cancer are
available from large, publicly available databases including surveys and public health records. We
can use these estimates to evaluate whether program goals have been met and to predict whether
future goals such as those set by the Healthy People 2010 (http://www.healthypeople.gov/) are
obtainable. In addition, models describing screening dissemination may be used by microsimu-
lation modelers such as the Cancer Intervention and Surveillance Modeling Network (CISNET:
http://cisnet.cancer.gov/) to estimate the contribution of screening to observed changes in cancer
incidence and mortality (e.g., Berry, 2005).
In this paper, we develop a model for the dissemination of endoscopy examinations in the United
States from 1975 to 2003. Our long term goal is estimation of the contribution of endoscopy to
observed changes in national colorectal cancer incidence and mortality rates. To meet this goal, our
endoscopy dissemination model will be applied to microsimulation models developed by three CIS-
NET groups: Group Health Cooperative (Rutter, Miglioretti, Savarino, in prep), Sloan-Kettering
Institute for Cancer Research/MISCAN (Loeve, et al., 1999), and Harvard School of Public Health
(Knudsen, 2005; Frazier, et al., 2000) in future research. Descriptions and comparisons of these
microsimulation models can be found at http://cisnet.cancer.gov/profiles/.
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1.1 Available Data Sources
To assess screening behaviors in the United States, Epidemiologists rely heavily on two surveys:
the National Health Interview Survey (NHIS) and the Behavioral Risk Factor Surveillance System
(BRFSS). The NHIS is a household in-person interview conducted by the Center for Disease Con-
trol’s National Center for Health Statistics. The NHIS uses a multistage area probability design
which permits representative sampling of households to provide national estimates of health be-
haviors (http://www.cdc.gov/nchs/nhis.htm). The NHIS covers the civilian noninstitutionalized
population of the United States and includes approximately 43,000 households and 106,000 persons
per year. The annual response rate is greater than 90% of eligible households.
The BRFSS is a large (approximately 160,000 participants per year) telephone survey developed
to monitor state-level health risks and behaviors (http://www.cdc.gov/brfss/). It is administered
and supported by the Center for Disease Control’s National Center for Chronic Disease Prevention
and Health Promotion. The BRFSS is limited to families with land-line telephones and the response
rate is lower than the NHIS, ranging across states from 46% to 93% (median 77%) in 1997. Most
states use disproportionate stratified sampling to allow estimation at the region as well as the state
level. All states and Washington, D.C. adopted this sampling approach by 2001.
The NHIS and BRFSS have complementary advantages that make it desirable to include both
data sources for estimating the age at first endoscopy. The high response rate of the NHIS and
the fact that it is an in-person interview likely make it less biased than the BRFSS. However, the
BRFSS is a larger survey and asked about endoscopy examinations in more years.
1.2 Modeling Challenges
In developing our model for age at first endoscopy, we faced three main challenges: First, we can
not easily obtain empirical estimates of the age at first endoscopy over the entire time-period of
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interest (1975-2003), because available survey data consists of questions of the form “Have you
ever had [the screening test under study ].” Thus, at each survey year, we observe the proportion
of participants that have had an endoscopy prior to the time of the survey. This type of data
is referred to as current status data (Jewell and van der Laan, 2002). Second, because national
survey data was not available until 1987, there is a substantial time period during which we have
no information about endoscopy use. A third challenge was including data from both the NHIS and
BRFSS to increase the amount of information about the dissemination of endoscopy. While the
NHIS is designed for estimation at the national or regional level, the BRFSS was designed to make
inference at the state level and most states did not ask about endoscopy in all years; therefore,
state-level diﬀerences must be taken into account to adjust for missing data as well as for clustering
within states.
To overcome these challenges, we use a theoretically motivated parametric model from the
diﬀusion of innovation literature (Mahajan and Peterson, 1985) to extrapolate from information
observed in 1987 to 2003 to estimate the rate of adoption in the earlier years. Cronin et al.
(2005) used a mixed-influence diﬀusion model to model time to first mammography examination
separately by birth cohort based on NHIS data only. We extend their model by incorporating
covariate eﬀects to pool information across birth cohorts to better estimate the rate of endoscopy
adoption over time. Further, to combine information from the NHIS and BRSS to make inference
about the national-level diﬀusion model parameters, we link a state-specific model to the national-
level diﬀusion model of interest using a marginalized modeling approach (Heagerty and Zeger, 2000;
Heagerty, 2002; Miglioretti and Heagerty, 2004).
In the next section, we introduce our national-level and state-specific mixed-influence diﬀusion
models. In section 3, we describe our methodology for estimating the national-level diﬀusion model
parameters of interest. In section 4, we fit the model to the NHIS and BRFSS data to estimate the
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diﬀusion of endoscopy. We close with a discussion of our approach.
2 Marginalized diﬀusion model
We sought to combine information from the NHIS and the BRFSS at multiple survey years to
obtain national-level estimates of the diﬀusion of endoscopy use over time by birth year and gender.
Diﬀusion of innovations models are widely used in economics and social research to model the
adoption of new products or behaviors by a population. We propose using a specific type of
diﬀusion model, the mixed influence diﬀusion model (Mahajan and Peterson, 1985), to model the
age at first endoscopy examination in the United States. This model accounts for influences from
both external sources, such as mass media and physicians, and internal sources, such as discussions
with friends and family. In addition, the model can be parameterized to allow a proportion of the
population to never be screened. The regression model we use is based on the following diﬀerential
equation that describes the rate of change in endoscopy use at time T as:
dpN (t < T )
dt
=
¡
a+ bpN (t < T )
¢ ¡
c− pN (t < T )
¢
(1)
where pN (t < T ) is the proportion of individuals in the United States that have had an endoscopy
examination before time T, a > 0 measures the external influence, b > 0 measures the internal
influence, and 0 < c < 1 is the proportion of people who will ever have an endoscopy. Thus,
c− pN (t < T ) is the proportion of potential adopters remaining at time T. Integration of equation
(1) gives a model for the national cumulative incidence of endoscopy use over time:
pN (t < T ) =
ac(1− exp [− (a+ bc) (T − t0)])
a+ bc exp [− (a+ bc) (T − t0)]
(2)
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where t0 is the year endoscopy was first introduced for general use. Figure 1 displays mixed-
influence diﬀusion curves for a range of values of a, b, and c. Increasing the external influence
parameter a has an immediate eﬀect on increasing the diﬀusion curve, because external influences
do not depend on how many people have had an endoscopy. In contrast, increasing the internal
influence parameter b has a more delayed eﬀect on the diﬀusion curve. As more people have an
endoscopy, the diﬀusion rate increases at a faster rate for larger values of b. A delay in the rise of
the diﬀusion curve could also occur if there is a delay in use of endoscopy until a certain age. For
example, for younger birth cohorts, there may be a delay in the use of endoscopy until the cohort
reaches the age at which guidelines recommend use of endoscopy for screening (typically age 50).
This would result in an increase in b with increasing birth year. As the asymptote c increases, a
larger proportion of people eventually have an endoscopy.
Figure 1: Mixed-influence diﬀusion curves, pN (t < T ), for diﬀerent values of a, b, and c.
We allow the cumulative incidence of endoscopy use to depend on covariates such as birth year
by modeling each diﬀusion parameter as a function of covariates x. Substituting fα (x) , fβ (x) ,
and fη (x) for a, b, and c, respectively, we use a log-link for the influence parameters fα (x) and
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fβ (x) and a logit-link for the asymptote fη (x) to maintain the parameter constraints:
log (fα (x)) = α0 + α1x
log (fβ (x)) = β0 + β1x
log
µ
fη (x)
1− fη (x)
¶
= η0 + η1x.
Incorporating these functions into equation (2) gives a cumulative incidence model conditional on
covariates:
pN (t < T |α,β,η,xk,x) = fα (x) fη (x) (1− exp [− (fα (x) + fβ (x) fη (x)) (T − t0)])fα (x) + fβ (x) fη (x) exp [− (fα (x) + fβ (x) fη (x)) (T − t0)] (3)
For parameter estimation, equation (3) can be directly applied to data from the NHIS when account-
ing for survey weights, because the NHIS was designed to provide estimates that are representative
at the national level. The NHIS sample size is too small to make inferences about states, and the
public data set does not contain information about an individual’s state of residence. In contrast,
the BRFSS was designed to provide estimates at the state level; however, in some years, only some
states asked about endoscopy use. Because states that did not ask about endoscopy use are likely
to be diﬀerent from states that did, missing data are probably not missing completely at random
and thus estimates based only on available data will not be nationally representative. Therefore,
state diﬀerences must be taken into account when estimating national-level parameters. To do this,
we introduce a state-level model for the probability of having a previous endoscopy examination by
survey year j for the ith state and the kth covariate combination xk given state-specific eﬀects θi :
pS (t < j|∆jk (α,β,η, θi,xk) , θi) = expit (∆jk (α,β,η, θi,xk) + θi) (4)
θi ∼ Normal
¡
0, σ2
¢
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where expit(·) is the inverse-logit function and ∆jk (α,β,η, θi,xk) is a tractable function of the
diﬀusion model parameters α, β,and η, the state-specific eﬀects θi, the survey year j and the
covariates xk. In the following, we drop the notational dependence of ∆jk on (α,β,η, θi,xk) for
simplicity, unless it is useful for clarification. Note that all 50 states plus Washington, D.C. are
included in the BRFSS for a total of 51 state-specific eﬀects.
The state-level model intercepts ∆ link the state-level model to the national-level model para-
meters and are fully determined by the relationship between the national and state-specific curves.
The expected value of the state-specific probabilities pS (t < j|∆jk (α,β,η, θi,xk) , θi) taken with
respect to the states (i) must equal the national-level probability for that survey year and covariate
combination pN (t < j|α,β,η,xk):
pN (t < j|α,β,η,xk) = E(i)
£
pS (t < j|∆jk (α,β,η, θi,xk) , θi)
¤
(5)
=
1P51
i=1Nijk
51X
i=1
pS (t < j|∆jk (α,β,η, θi,xk) , θi)Nijk.
where Nijk is the ith state’s population size for the kth covariate combination during the jth survey
year. We solve equation (5) for the state-level model intercepts∆ using Newton-Raphson with Nijk
taken from the census (http://www.census.gov).
3 Model Estimation
For unbiased national and state-level parameter estimates, we need to account for the survey
sampling designs. Because the design variables are not available in the NHIS or BRFSS public data
sets, we must rely on the survey weights provided in the public data files. Let h = 1 for the NHIS
and h = 2 for the BRFSS. Let nhijk be the number of individuals surveyed with survey h from state i
during year j with the kth covariate combination, i = 1, . . . , 51; j = 1, . . . , Jhi; k = 1, . . . ,K, and let
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yhijk be the number of surveyed individuals that said they have ever had an endoscopy examination.
For notational purposes, we replace the state-level subscript i with · when h = 1, because state of
residence is not available in the NHIS public use data sets. We use the survey weights whijk to create
a pseudo-sample with y∗hijk = whijkyhijk positive responses and nhijk − y∗hijk = whijk (nhijk − yhijk)
negative responses for each survey h, state i, survey year j, and covariate combination k (Cronin
et al., 2005). We take the weight whijk to be the sum of the standardized survey weights, summed
over the number of individuals surveyed and standardized to sum to the total survey sample sizePK
k=1 nhijk. This pseudo-sample approach results in a weighted version of the likelihood that
is equivalent to the pseudo-likelihood commonly used in the analysis of survey data (Korn and
Graubard, 1999; Chambers and Skinner, 2003).
As discussed in the previous section, the NHIS provides nationally representative data; therefore,
assuming the weighted observations are conditionally independent given the model, the likelihood
component for the NHIS pseudo-data y∗1 may be written as a function of the national model (3):
p (y∗1|α,β,η,x) ∝
Jh·Y
j=1
KY
k=1
pN (t < j|α,β,η,xk)y
∗
1·jk
¡
1− pN (t < j|α,β,η,xk)
¢n1·jk−y∗1·jk ,
where pN (t < j|α,β,η,x) is defined in equation (3). The BRFSS provides data that are represen-
tative at the state level, and as discussed in the previous section, diﬀerences between states must
be taken into account due to missing data for some states in some survey years; therefore, we write
the likelihood component for the BRFSS pseudo-data y∗2 in terms of the state-specific model (4).
Assuming outcomes within a state are independent conditional on the state-specific eﬀects θ, the
likelihood for the BRFSS may be written as follows:
p (y∗2|α, β, η,xk,θ) ∝
51Y
i=1
JiY
j=1
KY
k=1
pS (t < j|α,β,η,xk, θi)y
∗
2ijk
¡
1− pS (t < j|α,β,η,xk, θi)
¢n2ijk−y∗2ijk ,
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where pS (t < j|α,β,η,xk, θi) is defined in equation (4). We take the full likelihood to be the
product of the likelihoods for the NHIS and BRFSS. While we recognize that observations within
the same state may not be independent across the two surveys, we do not have information about
an individual’s state for the NHIS, so we can not take this dependence into account.
We use Markov Chain Monte Carlo (MCMC) to sample from the posterior distribution, which
is proportional to the product of the prior distributions and the likelihood:
p (α,β,η,θ, σ|y∗,x) ∝ p (α) p (β) p (η) p (σ)
51Y
i=1
p (θi|σ) (6)
p (y∗1|α,β,η,x) p (y∗2|α,β,η,x,θ)
We use standard prior distributions, takingα, β, and η to be Normal(0, 100) and σ to be Uniform(0, 10).
In the style of Gibbs sampling (Gelfand and Smith, 1990), we update each set of parameters condi-
tional on the remaining parameters using Metropolis (random walk) steps (Metropolis, et al., 1953;
Gilks, Richardson, and Spiegelhalter, 1996).
4 Application
We used the marginalized diﬀusion model to estimate the age at first endoscopy examination from
current status data collected by the NHIS and BRFSS. The NHIS asked about any prior endoscopy
examination in 1987, 1992, 1998, 2000, and 2003. For the BRFSS, all states asked about prior
endoscopy in 1997, 1999, 2001, and 2002, while only some states asked about endoscopy in 1989-
1996, 1998, 2000, and 2003. The wording of the question varied by year and survey, but in general,
asked “Have you ever had a [exam-type]?” where [exam-type] was one of the following: “procto-
scopic exam,” “sigmoidoscopy or colonoscopy,” “sigmoidoscopy or proctoscopy,” or “sigmoidoscopy,
colonoscopy, or proctoscopy.” In most years, women and men ages 40 and over were asked about
9
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prior endoscopy. In 2001, the BRFSS started only asking the question to people 50 and over. For
analysis, if the person answered that they did not know or were unsure if they ever had an exam-
ination (<1% of observations), we assumed they never had the examination. We excluded people
that refused to answer the question (<1%).
*** TABLE 1 ABOUT HERE ***
Tables 1 displays the sample sizes and weighted percentages of men and women that reported
ever having an endoscopy. In 1987, the first year the NHIS asked about endoscopy, weighted
estimates of the percentage of people that had a prior endoscopy from the NHIS ranged from 13%
for women and 15% for men born 1940-1949 to 27% for women and 33% for men born 1910-1929.
By 2003, this number increased to 40% for women and 43% for men born 1940-1949 and to 43%
for women and 55% for men born 1910-1929.
We fit separate models for males and females. Because endoscopy was first used in the mid
1970’s, we take t0 to be 1975. To increase computational speed, we grouped people into 10 year
birth cohorts for analysis, including the mean birth year for each group as the covariate value.
Because the sample size is very small for the oldest birth cohorts, we grouped people born from
1910 to 1919 with those born in 1920. The diﬀusion curves are expected to be similar for these
birth cohorts, because they would have all been of screening age (50 or older) at the time endoscopy
was introduced.
For each model, we ran three samplers starting at dispersed values for 600,000 iterations each,
discarded the first 100,000 iterations for burn-in, and kept every 20th iteration for analysis. Results
are based on the 75,000 remaining iterations from the three combined samplers. To check conver-
gence, we examined trace plots and compared the three samplers to verify convergence to the same
posterior modes.
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Table 2. Parameter estimates and 95% highest posterior density (HPD)
intervals.
Females Males
Parameter Estimate 95% HPD Estimate 95% HPD
α0 -3.14 (-3.22, -3.06) -2.58 (-2.68, -2.46)
β0 -2.20 (-2.28, -2.12) -2.20 (-2.38, -1.98)
η0 0.24 (0.19, 0.29) 0.30 (0.25, 0.33)
α1 -0.092 (-0.096, -0.088) -0.087 (-0.092, -0.082)
β1 0.0030 (0.0004, 0.0053) -0.0084 (-0.013, -0.0019)
η1 0.096 (0.089, 0.10) 0.064 (0.054, 0.073)
σ 0.15 (0.13, 0.20) 0.21 (0.17, 0.26)
Diﬀusion model parameter estimates (posterior modes) along with 95% highest posterior den-
sity intervals are shown in Table 2. Note that the HPD intervals are approximate, because we
did not adjust for clustering within strata and probability sampling units (PSUs), and we used a
pseudo-sample for estimation. None-the-less, these intervals provide a general idea of the magni-
tude of variability in these estimates, assuming there is not a large amount of correlation within
unacknowledged clusters.
Figure 2: Diﬀusion model parameter estimates by birth year.
Figure 2 displays how the diﬀusion model parameter estimates change with birth year. For both
males and females, the external influence parameter decreases rapidly with increasing year of birth.
Males in the oldest cohort have a larger external influence parameter compared to women, but
11
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Figure 3: Estimated endoscopy diﬀusion curves for males and females born from 1910-1920 and in
1930, 1940, and 1950. N = weighted percentages from NHIS, B = weighted percentages from the
BRFSS in years that all states were surveyed, and b = weighted percentages from the BRFSS in
years when only some states were surveyed.
this diﬀerence diminishes with increasing year of birth. In contrast, the oldest males and females
have a similar internal influence parameter, but with increasing birth year, the internal influence
parameter increases for females and decrease for males, resulting in a larger internal influence
parameter for younger females relative to males. Men and women in the oldest birth cohort have
similar asymptotes, however, these asymptotes diverge as birth year increases, suggesting more
males will eventually receive an endoscopy than females among the younger birth cohorts. However,
care must be taken when interpreting the asymptote parameter, especially for the younger birth
cohorts, because it requires extrapolation outside the observed range of data. Variability between
states (Table 2) is somewhat larger for males than females.
Figure 3 shows the endoscopy diﬀusion curves for females and males born in 1920, 1930, 1940
and 1950. The fitted curves fit the observed data very well in years that all states were surveyed.
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5 Discussion
In this paper, we present an approach for modeling the diﬀusion of a cancer test within a population
based on current status data collected via national surveys. We incorporate covariate eﬀects into
a theoretically motivated mixed-influence diﬀusion model (Mahajan and Peterson, 1985) to pool
information across multiple birth cohorts to estimate the rate of test adoption based on current
status data observed during a limited time-period. We use marginalized modeling methodology
to make inference about national-level parameters, combining data from two surveys: the NHIS,
which is representative at the national or regional level and the BRFSS, which is representative at
the state level. Our methodology diﬀers from other marginalized random eﬀects models (Heagerty
and Zeger 2000; Diggle, Heagerty, Liang, and Zeger, 2002; Miglioretti and Heagerty, 2004 ) in that
the conditional (state-level) and marginal (national-level) models are linked through a weighted
average across a fixed number of state-specific models as opposed to an integral over the entire
random eﬀect distribution.
One advantage of the marginalized modeling approach is that the structure of the mean model
is not constrained by the study design or the desired fitting method. By using this approach, we
were able to directly model the marginal (national) mean of interest while separately specifying
a state-specific model used in the likelihood for the BRFSS. Generalized estimating equations
(GEE; Liang and Zeger, 1986) are commonly used when substantive interest is in the marginal
or population-average regression structure. However, without modification, GEE may give biased
results when data are not missing completely at random (Laird, 1988; Robins et al., 1995). The
marginalized modeling approach uses likelihood-based methods, which are robust when data are
missing at random.
We estimated model parameters using data from two surveys: the NHIS and BRFSS. The NHIS
is generally believed to be less biased than the BRFSS, because the BRFSS excludes households
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without land-line telephones and has a lower response rate than the NHIS. The rates of endoscopy
use reported here are higher for the BRFSS compared to the NHIS, suggesting some bias in the
BRFSS. However, we include the BRFSS for estimation, because the NHIS only asked about col-
orectal cancer testing in a limited number of years late in the diﬀusion process. There has been
some research on adjusting for bias in the BRFSS when combining data from these two surveys for
small area estimation. Elliott and Davis (2005) use a propensity score approach while Raghunathan
et al. (2006) directly adjust for an eﬀect of having a telephone. It may be possible to incorporate
a telephone eﬀect into our model, however, we are not interested in separate diﬀusion curves for
people with and without telephones. Therefore, we would need to marginalize over the telephone
eﬀect for estimation of national-level parameters of interest, which would add an additional level
of complexity to our model.
We acknowledge that the use of a pseudo-sample is ad hoc. Design variables are not available
in the NHIS and BRFSS public use data sets, and accounting for complex survey designs using
likelihood methods is challenging without design variables (Korn and Graubard, 1999; Chambers
and Skinner, 2003). The pseudo-likelihood is commonly used in the analysis of complex surveys
and has good design-based properties (e.g., consistency). In addition, the pseudo-likelihood can
be justified from an analytic perspective (Binder and Roberts, 2003). Because our interest is in
estimation of the finite-population (i.e., national) values of the diﬀusion model parameters, the
pseudo-likelihood should perform well; however, more research into the use of weighted likelihoods
in Bayesian methods is needed.
For our microsimulation models, we only require estimates of model parameters and not variance
estimates. Unbiased variance estimation is diﬃcult in this case for several reasons. First, we are
combining data from two possibly overlapping national surveys and information about common
clusters (e.g., states, counties, strata, and PSUs) between the two surveys is not available. Second,
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we are combining information across multiple years and information about common clusters across
years is not available. Last, design variables are not available in the public use data sets. To
improve variance estimation, we could incorporate strata and PSU-specific eﬀects into another
level of conditional models for the NHIS and BRFSS and marginalize over these eﬀects; however,
this would further complicate our model and is not necessary for our purposes.
Three CISNET groups will use these diﬀusion model parameter estimates as microsimulation
model inputs. We will combine the results from these models with a model for the time be-
tween endoscopy examinations. From this two-part model, we will generate endoscopy histories
for individuals in our simulated populations. Examples of such input parameter generators used
by CISNET groups, including one based on the model described in this paper, can be found at
http://cisnet.cancer.gov/interfaces/. By comparing outcomes of interest (e.g., cancer incidence and
mortality) from the same simulated population with and without endoscopy use, we will estimate
the eﬀects of endoscopy on these outcomes. In this way, microsimulation models can greatly con-
tribute to our understanding of the benefits of endoscopy without the cost and time associated with
large randomized trials.
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Survey N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
NHIS
1987 51 2,935 (27%) 1,414 (22%) 1,451 (13%) 0 N/A 0 N/A 1,827 (33%) 1,120 (22%) 1,178 (15%) 0 N/A 0 N/A
1992 51 1,367 (35%) 769 (29%) 995 (21%) 387 (11%) 0 N/A 815 (44%) 590 (31%) 810 (25%) 295 (16%) 0 N/A
1998 51 3,003 (38%) 1,941 (33%) 2,585 (25%) 3,024 (13%) 0 N/A 1,770 (50%) 1,502 (47%) 2,048 (30%) 2,542 (17%) 0 N/A
2000 51 2,533 (43%) 1,822 (41%) 2,367 (30%) 3,272 (14%) 350 (09%) 1,442 (49%) 1,366 (47%) 1,947 (33%) 2,660 (15%) 310 (08%)
2003 51 2,023 (43%) 1,704 (47%) 2,292 (40%) 3,118 (20%) 1,365 (11%) 1,012 (55%) 1,194 (55%) 1,860 (43%) 2,526 (21%) 1,153 (11%)
BRFSS
1988 7 1,169 (45%) 580 (35%) 725 (18%) 0 N/A 0 N/A 645 (55%) 416 (37%) 499 (34%) 0 N/A 0 N/A
1989 7 1,008 (48%) 553 (30%) 757 (19%) 0 N/A 0 N/A 589 (56%) 375 (41%) 546 (29%) 0 N/A 0 N/A
1990 6 909 (46%) 479 (31%) 734 (22%) 102 (13%) 0 N/A 512 (58%) 355 (44%) 535 (37%) 73 (12%) 0 N/A
1991 7 1,171 (49%) 680 (34%) 905 (26%) 234 (16%) 0 N/A 609 (57%) 459 (45%) 642 (30%) 165 (18%) 0 N/A
1992 4 715 (45%) 478 (37%) 649 (24%) 257 (14%) 0 N/A 432 (61%) 338 (42%) 450 (30%) 183 (20%) 0 N/A
1993 50 12,190 (39%) 6,545 (34%) 9,052 (20%) 4,804 (12%) 0 N/A 6,875 (47%) 4,777 (39%) 7,042 (24%) 3,868 (14%) 0 N/A
1994 4 1,101 (38%) 607 (34%) 844 (21%) 542 (13%) 0 N/A 555 (45%) 459 (40%) 689 (25%) 432 (13%) 0 N/A
1995 49 12,089 (38%) 7,208 (33%) 9,415 (21%) 7,729 (13%) 0 N/A 6,689 (52%) 5,074 (43%) 7,111 (26%) 5,977 (14%) 0 N/A
1996 4 1,026 (34%) 698 (33%) 870 (20%) 842 (12%) 0 N/A 559 (45%) 464 (41%) 645 (25%) 658 (14%) 0 N/A
1997 51 13,192 (44%) 8,769 (40%) 11,409 (27%) 12,517 (15%) 0 N/A 6,971 (52%) 6,061 (47%) 8,585 (32%) 9,798 (16%) 0 N/A
1998 2 550 (47%) 350 (34%) 421 (27%) 550 (14%) 0 N/A 239 (48%) 248 (43%) 310 (33%) 424 (16%) 0 N/A
1999 51 13,422 (48%) 10,474 (45%) 13,544 (32%) 18,414 (16%) 0 N/A 6,706 (56%) 6,965 (52%) 9,933 (36%) 13,833 (16%) 0 N/A
2000 4 739 (46%) 711 (44%) 969 (36%) 1,298 (17%) 158 (09%) 385 (63%) 430 (51%) 674 (36%) 1,022 (17%) 127 (14%)
2001 51 14,764 (54%) 13,214 (52%) 17,707 (42%) 4,594 (29%) 0 N/A 7,219 (59%) 8,804 (53%) 12,497 (41%) 3,264 (28%) 0 N/A
2002 51 17,812 (56%) 17,368 (56%) 22,079 (44%) 8,296 (33%) 0 N/A 8,516 (61%) 10,863 (57%) 15,512 (45%) 6,061 (31%) 0 N/A
2003 10 3,171 (58%) 3,444 (58%) 4,633 (48%) 2,296 (36%) 0 N/A 1,584 (62%) 2,251 (61%) 3,060 (49%) 1,624 (35%) 0 N/A
*Includes Washington D.C.
1950-1959 1960-1963
Table 1. Survey sample size and weighted percentage reporting they had ever had an endoscopy exam from the NHIS and BRFSS by birth cohort and gender.
MalesFemales
1910-1929 1930-1939 1940-1949 1950-1959 1960-1963 1910-1929 1930-1939 1940-1949N 
States*
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